314930 Stock Chart & Stats
₩7500.00
-₩600.00(-7.41%)
―
--
Day’s Range― - ―
52-Week Range₩6,600.00 - ₩16,860.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)48.31K
Market Cap
₩238.76B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)153.3
Beta0.39
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding29,764,103
10 Day Avg. Volume43,070
30 Day Avg. Volume48,315
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)156
Revenue Forecast (FY)₩11.90B
314930 FAQ
What was BIODYNE Co., Ltd.’s price range in the past 12 months?
BIODYNE Co., Ltd. lowest stock price was ₩6600.00 and its highest was ₩16860.00 in the past 12 months.
What is BIODYNE Co., Ltd.’s market cap?
BIODYNE Co., Ltd.’s market cap is ₩238.76B.
When is BIODYNE Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BIODYNE Co., Ltd.’s earnings last quarter?
BIODYNE Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩5.271 earnings per share for the quarter, beating the consensus estimate of N/A by ₩5.271.
Is BIODYNE Co., Ltd. overvalued?
According to Wall Street analysts BIODYNE Co., Ltd.’s price is currently Undervalued.
Does BIODYNE Co., Ltd. pay dividends?
BIODYNE Co., Ltd. does not currently pay dividends.
What is BIODYNE Co., Ltd.’s EPS estimate?
BIODYNE Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BIODYNE Co., Ltd. have?
BIODYNE Co., Ltd. has 29,764,103 shares outstanding.
What happened to BIODYNE Co., Ltd.’s price movement after its last earnings report?
BIODYNE Co., Ltd. reported an EPS of ₩5.271 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.326%.
Which hedge fund is a major shareholder of BIODYNE Co., Ltd.?
Currently, no hedge funds are holding shares in KR:314930
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kolon Life Science Inc.
―
HUMEDIX Co.LTD.
―
Boditech Med, Inc.
―
PROTEINA Co., Ltd.
―
IMBiologics Corp.
―